KR20140128314A - 다중특이적 결합제의 결합 파트너 검출 방법 - Google Patents

다중특이적 결합제의 결합 파트너 검출 방법 Download PDF

Info

Publication number
KR20140128314A
KR20140128314A KR1020147021674A KR20147021674A KR20140128314A KR 20140128314 A KR20140128314 A KR 20140128314A KR 1020147021674 A KR1020147021674 A KR 1020147021674A KR 20147021674 A KR20147021674 A KR 20147021674A KR 20140128314 A KR20140128314 A KR 20140128314A
Authority
KR
South Korea
Prior art keywords
antibody
antigen
sample
binding
bispecific antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020147021674A
Other languages
English (en)
Korean (ko)
Inventor
카이-군나르 슈투벤라우히
우베 베쎌스
Original Assignee
에프. 호프만-라 로슈 아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에프. 호프만-라 로슈 아게 filed Critical 에프. 호프만-라 로슈 아게
Publication of KR20140128314A publication Critical patent/KR20140128314A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
KR1020147021674A 2012-02-01 2013-01-29 다중특이적 결합제의 결합 파트너 검출 방법 Ceased KR20140128314A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP12153457.2 2012-02-01
EP12153457 2012-02-01
EP12182505.3 2012-08-31
EP12182505 2012-08-31
PCT/EP2013/051604 WO2013113663A1 (en) 2012-02-01 2013-01-29 Method for the detection of a binding partner of a multispecific binder

Publications (1)

Publication Number Publication Date
KR20140128314A true KR20140128314A (ko) 2014-11-05

Family

ID=47624068

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020147021674A Ceased KR20140128314A (ko) 2012-02-01 2013-01-29 다중특이적 결합제의 결합 파트너 검출 방법

Country Status (10)

Country Link
US (3) US9945869B2 (cg-RX-API-DMAC7.html)
EP (1) EP2810074B1 (cg-RX-API-DMAC7.html)
JP (3) JP2015507193A (cg-RX-API-DMAC7.html)
KR (1) KR20140128314A (cg-RX-API-DMAC7.html)
CN (2) CN104105966B (cg-RX-API-DMAC7.html)
BR (1) BR112014017630A8 (cg-RX-API-DMAC7.html)
CA (1) CA2859268A1 (cg-RX-API-DMAC7.html)
MX (1) MX349661B (cg-RX-API-DMAC7.html)
RU (1) RU2620563C2 (cg-RX-API-DMAC7.html)
WO (1) WO2013113663A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20140128314A (ko) 2012-02-01 2014-11-05 에프. 호프만-라 로슈 아게 다중특이적 결합제의 결합 파트너 검출 방법
EP2872893B1 (en) 2012-07-13 2017-03-29 F. Hoffmann-La Roche AG Method for the detection of a multispecific antibody
JP6446044B2 (ja) * 2013-11-05 2018-12-26 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 結合分子の存在下で被検体の総量および/または総濃度を決定するための方法、ならびにそれに関係するキット、組成物および使用
CN104109197B (zh) * 2013-11-13 2017-05-10 叶森 一种双识别抗体片段的制备方法及其应用
CN108139394B (zh) * 2015-10-02 2020-10-30 豪夫迈·罗氏有限公司 用于确定同时结合的基于细胞的fret测定法
MA43028B1 (fr) 2015-10-02 2021-09-30 Hoffmann La Roche Anticorps bispécifiques pour pd1 et tim3
ES2927977T3 (es) * 2017-02-06 2022-11-14 Biotempt Bv Moduladores peptídicos de la interacción entre el péptido C humano y el receptor de elastina humana para uso terapéutico
KR102461885B1 (ko) 2017-04-03 2022-11-03 에프. 호프만-라 로슈 아게 항-pd-1 항체와 돌연변이 il-2 또는 il-15의 면역접합체
CA3052532A1 (en) 2017-04-05 2018-10-11 F. Hoffmann-La Roche Ag Bispecific antibodies specifically binding to pd1 and lag3
JP7370322B2 (ja) 2018-06-04 2023-10-27 中外製薬株式会社 複合体を検出する方法
EP3969907B1 (en) * 2019-05-13 2025-09-24 F. Hoffmann-La Roche AG Interference-suppressed pharmacokinetic immunoassay
WO2022065052A1 (ja) * 2020-09-24 2022-03-31 株式会社Jvcケンウッド 捕捉用抗体、固相担体、検出用抗体、固相担体粒子、並びに検出対象物質の測定キット及び測定方法
CN117805397A (zh) * 2024-02-29 2024-04-02 军科正源(北京)药物研究有限责任公司 检测游离vegf的方法

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5219730A (en) 1982-09-28 1993-06-15 New York University Idiotype-anti-idiotype immunoassay
US4828981A (en) 1983-08-24 1989-05-09 Synbiotics Corporation Immunoassays for determining Dirofilaria immitis infection using antiidiotype monoclonal antibody reagents
EP0170302A1 (fr) 1984-06-27 1986-02-05 l'Association internationale à but scientifique, dite: Institut international de pathologie cellulaire et moléculaire Procédé de dosage immunologique d'une substance dans un échantillon liquide au moyen d'anticorps anti-idiotypiques
US5238808A (en) 1984-10-31 1993-08-24 Igen, Inc. Luminescent metal chelate labels and means for detection
WO1987002778A1 (en) 1985-10-22 1987-05-07 Cooper-Lipotech Solid-phase liposome immunoassay system
DE68928994T2 (de) 1988-11-03 1999-12-16 Igen International, Inc. Elektrochemilumineszente testverfahren
US5068088A (en) 1988-11-03 1991-11-26 Igen, Inc. Method and apparatus for conducting electrochemiluminescent measurements
IL100866A (en) 1991-02-06 1995-10-31 Igen Inc Method and apparatus for magnetic microparticulate based luminescence assay including plurality of magnets
DE69332377T2 (de) 1992-07-13 2003-07-03 Bionebraska, Inc. Verfahren zur modifizierung rekombinanter polypeptide
JPH097096A (ja) 1995-06-20 1997-01-10 Alpine Electron Inc 緊急車両接近時の報知方法
JPH0975096A (ja) * 1995-09-14 1997-03-25 Snow Brand Milk Prod Co Ltd ラクトフェリンの測定法
DE69828642T2 (de) 1997-11-21 2005-12-29 Inverness Medical Switzerland Gmbh Verbesserungen an oder in bezug auf verschiebungstests
JPH11352129A (ja) * 1998-06-04 1999-12-24 Mizuho Medeii:Kk 検出装置及び検出方法
US6753189B1 (en) 1998-06-04 2004-06-22 Mizuho Medy Co., Ltd. Detection apparatus and method for the same
CN100399030C (zh) * 1999-11-16 2008-07-02 杰南技术公司 用于vegf的elisa
GB0007088D0 (en) * 2000-03-23 2000-05-17 Torsana A S Detection of immunological memory determining the position of loci of pathologyand therapeutic t-cell conjugates
US6984494B2 (en) 2000-08-15 2006-01-10 Genentech, Inc. Analytical method
US7341837B2 (en) * 2003-09-02 2008-03-11 Lawton Robert L Soluble analyte detection and amplification
WO2006096697A2 (en) * 2005-03-08 2006-09-14 Tanox, Inc. Methods for determining the bivalency of protein and antibody therapeutics
US7494776B2 (en) * 2005-07-07 2009-02-24 Beckman Coulter, Inc. Labeled complementary oligonucleotides to detect oligonucleotide-linked ligands
SG164379A1 (en) 2005-07-21 2010-09-29 Genmab As Potency assays for antibody drug substance binding to an fc receptor
CN101268372A (zh) * 2005-07-21 2008-09-17 根马布股份公司 与fc受体结合的抗体药物的药效测定
DK2457929T3 (en) * 2006-10-04 2016-09-05 Genentech Inc Elisa vegf
EP1917854A1 (en) 2006-11-06 2008-05-07 F. Hoffmann-La Roche Ag Method for producing anti idiotypic antibodies
US8242247B2 (en) 2007-12-21 2012-08-14 Hoffmann-La Roche Inc. Bivalent, bispecific antibodies
US8227577B2 (en) 2007-12-21 2012-07-24 Hoffman-La Roche Inc. Bivalent, bispecific antibodies
US20090162359A1 (en) 2007-12-21 2009-06-25 Christian Klein Bivalent, bispecific antibodies
US9266967B2 (en) 2007-12-21 2016-02-23 Hoffmann-La Roche, Inc. Bivalent, bispecific antibodies
EP2297209A4 (en) 2008-06-03 2012-08-01 Abbott Lab IMMUNOGLOBULINS WITH TWO VARIABLE DOMAINS AND USES THEREOF
US20110195524A1 (en) * 2008-10-07 2011-08-11 Mats Inganas Semi-sequential assay for detection of an analyte in a sample
BRPI1014089A2 (pt) 2009-04-02 2016-04-19 Roche Glycart Ag anticorpos multiespecíficos que compreendem anticorpos de comprimento completo e fragmentos fab de cadeia simples
PT2417156E (pt) 2009-04-07 2015-04-29 Roche Glycart Ag Anticorpos trivalentes, biespecíficos
SG176219A1 (en) 2009-05-27 2011-12-29 Hoffmann La Roche Tri- or tetraspecific antibodies
US9676845B2 (en) 2009-06-16 2017-06-13 Hoffmann-La Roche, Inc. Bispecific antigen binding proteins
US8703132B2 (en) 2009-06-18 2014-04-22 Hoffmann-La Roche, Inc. Bispecific, tetravalent antigen binding proteins
WO2011048043A1 (en) * 2009-10-19 2011-04-28 F. Hoffmann-La Roche Ag NON-CROSS-REACTIVE ANTI IgG ANTIBODIES
CN102207504A (zh) * 2011-03-23 2011-10-05 北京华创远航科技有限公司 一种酶联检测试剂盒及其制备方法
CN104040350B (zh) 2011-12-19 2016-05-18 弗·哈夫曼-拉罗切有限公司 用于检测多特异性结合物的游离结合搭档的方法
KR20140128314A (ko) 2012-02-01 2014-11-05 에프. 호프만-라 로슈 아게 다중특이적 결합제의 결합 파트너 검출 방법
US20130231462A1 (en) * 2012-02-27 2013-09-05 Bio-Rad Laboratories, Inc. Anti-immune complex antibodies
EP2872893B1 (en) 2012-07-13 2017-03-29 F. Hoffmann-La Roche AG Method for the detection of a multispecific antibody

Also Published As

Publication number Publication date
WO2013113663A1 (en) 2013-08-08
MX2014008762A (es) 2014-08-27
RU2014133701A (ru) 2016-03-27
CN106443016B (zh) 2019-08-13
JP2019113564A (ja) 2019-07-11
MX349661B (es) 2017-08-08
BR112014017630A2 (cg-RX-API-DMAC7.html) 2017-06-20
CA2859268A1 (en) 2013-08-08
JP6678792B2 (ja) 2020-04-08
US20210055304A1 (en) 2021-02-25
JP6502441B2 (ja) 2019-04-17
HK1202921A1 (en) 2015-10-09
JP2017223710A (ja) 2017-12-21
JP2015507193A (ja) 2015-03-05
EP2810074A1 (en) 2014-12-10
US20140342382A1 (en) 2014-11-20
CN104105966A (zh) 2014-10-15
RU2620563C2 (ru) 2017-05-26
CN104105966B (zh) 2016-10-26
US9945869B2 (en) 2018-04-17
BR112014017630A8 (pt) 2017-07-11
EP2810074B1 (en) 2017-08-23
CN106443016A (zh) 2017-02-22
US20180328942A1 (en) 2018-11-15
US10761097B2 (en) 2020-09-01

Similar Documents

Publication Publication Date Title
JP6678792B2 (ja) 多重特異性結合物の結合パートナーを検出するための方法
JP6203747B2 (ja) 多特異性結合体の遊離結合パートナーの検出方法
CN104471397B (zh) 用于检测多特异性结合物的方法
US20120219974A1 (en) Distinguishing assay
CN107076761B (zh) 用于测定针对效应子功能抑制的人或人源化药物抗体的抗药物抗体的方法
HK1230718A1 (en) Method for the detection of a binding partner of a multispecific binder
HK1230718A (en) Method for the detection of a binding partner of a multispecific binder
HK1202921B (en) Method for the detection of a binding partner of a multispecific binder
HK1230718B (en) Method for the detection of a binding partner of a multispecific binder
HK1208731B (en) Method for the detection of a multispecific binder
HK1201920B (en) Method for the detection of free binding partner of a multispecific binder

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20140801

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20180115

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20190717

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20190925

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20190717

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I